Previous Article | Next Article 
J Virol, March 1998, p. 1994-2001, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Association of the Human Papillomavirus Type 11 E1 Protein with Histone H1
C. Scott
Swindle and
Jeffrey A.
Engler*
Department of Biochemistry and Molecular
Genetics, Schools of Medicine and Dentistry, University of Alabama
at Birmingham, Birmingham, Alabama 35294-0005
Received 27 August 1997/Accepted 9 December 1997
 |
ABSTRACT |
The E1 and E2 proteins are the only virus-encoded factors required
for human papillomavirus (HPV) DNA replication. The E1 protein is a DNA
helicase responsible for initiation of DNA replication at the viral
origin. Its recruitment to the origin is facilitated by binding to E2,
for which specific recognition elements are located at the origin. The
remaining replication functions for the virus, provided by the host
cell's replication machinery, may be mediated by further interactions
with E1 and E2. Histone H1 was identified as an HPV type 11 (HPV-11)
E1-binding protein by far-Western blotting and by microsequence
analyses of a 34-kDa protein purified by E1 affinity chromatography. E1
also bound in vitro to H1 isolated under native conditions in
association with intact nucleosomes. In addition, E1 and H1 were
coimmunoprecipitated by an E1 antiserum from a nuclear extract prepared
from cells expressing recombinant E1. Bound H1 was displaced from
HPV-11 DNA by the addition of E1, suggesting that E1 can promote
replication initiation and elongation by alteration of viral chromatin
structure and disruption of nucleosomes at the replication fork.
Furthermore, a region of the HPV-11 genome containing the origin of
replication was identified which had weaker affinity for H1 than that
of the remaining genome. This result suggests that the presence of a DNA structure at or near the HPV origin facilitates initiation of DNA
replication by exclusion of H1. These results are similar to those of
studies of simian virus 40 DNA replication, in which a large T
antigen-H1 interaction and an H1-resistant region at the origin of DNA
replication have also been demonstrated.
 |
INTRODUCTION |
Human papillomavirus type 11 (HPV-11) infects mucosal epithelia to induce benign anogenital and
laryngeal warts. Vegetative DNA replication, late gene expression, and
virus particle maturation are restricted to the upper layer of the
epithelium, which is composed of differentiated cells (8, 20, 44,
61, 62). No culture system for growth of HPV-11 in tissue culture
is available, and investigations of HPV-11 DNA replication have been
limited to transient or cell-free methods. With either of these types of replication assays, the E1 and E2 proteins are the only
virus-encoded factors which are required for replication of plasmids
harboring the viral origin of replication (12, 17, 38). The
E2 protein is a DNA-binding transcriptional transactivator for which
specific recognition elements are located at the origin (27,
43). The E1 protein is a DNA helicase which initiates viral DNA
synthesis from the origin (54, 71). Although E1 has a modest
affinity for origin DNA, its recruitment to the origin is facilitated
by binding to E2 (45, 70). The remaining required DNA
replication proteins are provided by the host cell.
Support of viral DNA replication by cellular replication factors is
commonly facilitated by interaction with viral replication proteins.
For example, DNA polymerase
-primase is recruited to the simian
virus 40 (SV40) and papillomavirus origins of replication by binding to
the large T antigen and E1 protein, respectively (50, 57).
To identify novel cellular proteins that might be involved in
papillomavirus DNA replication, we looked for proteins that interact
with the HPV-11 E1 protein. In these studies, histone H1 was identified
as an E1-binding protein found in HeLa cell nuclei. Data presented here
suggest that E1 facilitates papillomavirus replication by displacing H1
from DNA during the initiation and/or elongation phase of viral DNA
replication. Furthermore, a region containing the HPV-11 origin of
replication that excludes binding by H1, perhaps to facilitate
initiation of replication, was identified.
 |
MATERIALS AND METHODS |
Cell lines, viruses, and antibodies.
Unless otherwise
indicated, HeLa cells were used for all experiments and as the source
for nuclear matrices and native nucleosome complexes. Human 143B cells
were used for the selection of thymidine kinase (TK)-negative
recombinants during the construction of the recombinant E1 vaccinia
virus (vEE1). Both cell lines were maintained as monolayers in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal
bovine serum. For preparation of nuclear matrix extracts (NMEs), HeLa
S3 cells were grown in suspension cultures in spinner flasks.
The WR strain of vaccinia virus was used to generate the vEE1
recombinant vaccinia virus. The recombinant vaccinia virus encoding the
bacteriophage T7 RNA polymerase, vTF7-3 (24), was used to direct expression of E1 from vEE1. The recombinant vaccinia virus encoding the adenovirus fiber protein, 2F (31), was used for expression of the fiber protein in HeLa cells.
For immunoprecipitation and Western blot detection of the E1 protein,
the rabbit polyclonal antiserum RL-070 (
11), which
recognizes the amino terminus of E1, was used; a 1:5,000 dilution
was
employed for Western blotting. For immunoprecipitation and
Western blot
detection of histone H1, the purified mouse monoclonal
antibody AE-4
(Biogenesis Inc., Sandown, N.H.) was used. AE4 was
used at a 1:1,000
dilution in Western blot analyses using the
secondary avidin-biotin
detection scheme for signal amplification.
For immunoprecipitation and
Western blot detection of the adenovirus
fiber protein, the purified
mouse monoclonal antibody 4D2 (
32)
was used; a 1:5,000
dilution was used for Western blotting. For
detection of the
chloramphenicol acetyltransferase (CAT) and E1N
proteins in far-Western
blot analyses, the rabbit polyclonal antiserum
His-probe H-15 (Santa
Cruz Biotechnology, Santa Cruz, Calif.),
which recognizes the
polyhistidine tags on those proteins, was
used at a dilution of
1:5,000. All secondary goat anti-rabbit
or goat anti-mouse
immunoglobulin G antibodies conjugated to either
alkaline phosphatase,
biotin, or horseradish peroxidase (Pierce,
Rockford, Ill.) were used at
a dilution of 1:50,000.
35S-streptavidin (Amersham Life
Sciences, Arlington Heights, Ill.)
was used at a dilution of 1:1,000.
Enhanced chemiluminescence
(ECL; Amersham Life Sciences) was used for
Western blot detection
where indicated.
Construction of recombinant E1-expressing vaccinia virus and E1
expression.
The encephalomyocarditis virus (EMCV) untranslated
region (UTR) was fused by overlapping PCR (22) to the 5' end
of the E1 open reading frame (ORF). The sequences of the
oligonucleotide PCR primers used were as follows: 2235, 5'
CCGGATCCTAACGTTACTGGCCGAAGCCG 3'; 2953, 5'
CTCATTTTCTGTACCTGAATCGTCCGCCATATTATCATCGTGTTTTTCAAAGG 3';
2951, 5' CCTTGAAAAACACGATGATAATATGGCGGACGATTCAGGTACAGAAAATGAG 3'; and 3474, 5' CCAGCGGATCCCTGCATGCTCTCGGGTGCTGTC 3'.
EMCV DNA and the E1 cDNA (from L. T. Chow) were used as templates
in separate PCRs with oligonucleotide primer pairs 2235-2953
and
2951-3474, respectively. After purification to remove the
unused
primers, approximately 10-ng quantities of each of the
PCR products
from these reactions were combined and used together
as PCR templates
with oligonucleotides 2235 and 3474. This reaction
fused the EMCV UTR
to the N terminus of the E1 ORF, terminating
at the
SphI
site (nucleotide 1399). The termini of the PCR product
were digested
with
BamHI and ligated into pTF7.5 (
24)
linearized
with
BamHI to construct pTFEE1

SphI. The
remaining 3' portion
of the E1 ORF was excised from the E1 DNA plasmid
with
SphI and
ligated into pTFEE1

SphI linearized with
SphI to construct pTFEE1.
To recombine pTFEE1 into vaccinia
virus, HeLa cells were infected
with vaccinia virus strain WR at a
multiplicity of infection of
0.05 and subsequently transfected with
pTFEE1. At 48 h postinfection
(p.i.), the infected cells were
lysed by Dounce homogenization
in hypotonic buffer. Virus in the lysate
was plaque purified on
human 143B cells and simultaneously selected for
the TK-negative
phenotype by maintenance in DMEM containing 250 mM
bromodeoxyuridine.
Virus was isolated from individual TK-negative
plaques and screened
for E1 expression by determining reactivity to the
E1 RL-070 antiserum
in Western blot analysis. Plaque purification of a
positive isolate
was repeated as described above, and a stock of this
virus (vEE1)
was prepared.
For E1 expression, a vaccinia virus expressing the T7 RNA polymerase
(vTF7-3) (
24) and vEE1 were coadsorbed to HeLa cells
in a
100-mm-diameter tissue culture dish (multiplicity of infection,
10 each) in 1 ml of serum-free DMEM for 1 h. Infected cells were
maintained in complete medium until harvested. E1 expression was
detected as early as 7 h p.i. All vaccinia virus stocks used in
these studies were prepared as described by Moss and Earl
(
47).
Chicken erythrocyte histone H1.
Purified chicken erythrocyte
histone H1 was a gift from Heisaburo Shindo and was purified as
previously described (55).
Isolation of nucleosomes.
Native nucleosomes were prepared
as described by von Holt et al. (69). Briefly, uninfected
HeLa cell nuclei were digested with micrococcal nuclease in MN
digestion buffer (50 mM Tris [pH 7.4], 25 mM KCl, 4 mM
MgCl2, 1 mM CaCl2, 0.2 mM phenylmethylsulfonyl fluoride) for 30 min at 37°C and sedimented at 6,000 × g for 5 min at room temperature. The pellet was extracted by
Dounce homogenization in chromatin extraction buffer (10 mM Tris [pH
7.4], 0.25 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride) and dialyzed
overnight at 4°C against the same buffer. Residual proteins were
removed by centrifugation at 10,000 × g for 20 min at
4°C. Soluble histones were recovered in the supernatant.
Preparation of nuclear matrices and NMEs.
Nuclei were
isolated from uninfected or recombinant vaccinia virus-infected HeLa
cells as described by Challberg and Kelly (9). To prepare
nuclear matrices, nuclei were washed with digestion buffer (20 mM
Tris-HCl [pH 7.4], 0.05 mM spermine, 0.125 mM spermidine, 20 mM KCl,
70 mM NaCl, 10 mM MgCl2) at 4°C and digested with DNase I
at a concentration of 0.1 mg/ml for 1 h at the same temperature. Digested nuclei were sedimented by centrifugation at 13,000 × g for 5 min and extracted with digestion buffer containing
10 mM lithium-3,5-diiodosalicylate (LIS) at 4°C for 15 min. Nuclear matrices were sedimented as described above and washed three times with
digestion buffer at 4°C to remove the LIS. Nuclear matrix protein
concentrations were determined by the method of Bradford (7), in accordance with the manufacturer's instructions
(Bio-Rad Laboratories, Hercules, Calif.).
NME was prepared from uninfected HeLa cell nuclear matrix by a
procedure similar to that described by Angeletti and Engler
(
4). Nuclear matrices were extracted with 4 ml of NME
extraction
buffer (digestion buffer supplemented with 8 M urea and 1%
Triton
X-100) per 10 mg of nuclear matrix protein for 15 min at 4°C.
Residual proteins were removed by centrifugation at 13,000 ×
g and 4°C for 5 min. The supernatant was dialyzed
successively against
250 volumes each of digestion buffer containing 4, 2, 1, and 0.1
M urea for 2 h each at 4°C; this was followed by a
final dialysis
against digestion buffer at 4°C overnight. Glycerol
was added
to the NME (final concentration, 10%), and it was stored at

100°C.
Far-Western blot analysis.
Nuclear matrix proteins were
denatured by boiling in Laemmli sample buffer (39), and
residual proteins were removed by centrifugation at 13,000 × g for 15 s at room temperature. Proteins were resolved by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on
a 15% polyacrylamide gel and transblotted to nitrocellulose. Transblotted proteins were denatured, renatured, and blocked as described by Lee et al. (41). As probes, CAT and E1N were
allowed to bind to blotted proteins in TBS-Tx (50 mM Tris [pH 7.5],
250 mM NaCl, 1% Triton X-100) containing 5% bovine serum albumin and 5% glycerol for 2 h at room temperature. The blots were washed five times with TBS-Tx for 10 min each at room temperature and then
reacted with the His-probe antiserum in TBS-Tx containing 5% bovine
serum albumin for 1 h at room temperature. The blots were washed
as before and bound to secondary, horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G for 1 h at room temperature. The
blots were washed, and bound proteins were detected by enhanced chemiluminescence (Amersham Life Sciences).
Escherichia coli-expressed E1N and CAT.
The
pRSETE1 plasmid consisted of the full-length E1 ORF, fused at its N
terminus to polyhistidine, in the pRSET vector (Invitrogen, Carlsbad,
Calif.). pRSETE1N expressed the N-terminal portion of the E1 protein
truncated at amino acid 185 (E1N). For its construction, the
AccI restriction fragment between nucleotides 1376 and 1560 of the E1-coding region was excised. The cohesive termini were blunt
ended with the Klenow fragment of E. coli DNA polymerase I,
and the plasmid was recircularized by ligation. The pTrcHisCAT plasmid
(Invitrogen) encoded the CAT protein fused to polyhistidine. To express
E1N and CAT, E. coli BL21DE3plysS was transformed with each
plasmid and grown to mid-log phase. Cultures were induced for protein
expression with 1 mM isopropyl-
-D-thiogalactopyranoside (IPTG) at 37°C for 2 h. Bacteria were harvested by
centrifugation at 5,000 × g for 5 min at 4°C, lysed
with a French press in FP lysis buffer (50 mM NaPO4 [pH
8.0], 300 mM NaCl, 10% glycerol, 10 mM 2-mercaptoethanol), and
cleared of residual protein by centrifugation at 13,000 × g for 30 min at 4°C. The lysates were applied to
nickel-agarose affinity columns (Ni++-NTA; Qiagen, Santa
Clarita, Calif.), which were washed with Ni2+ wash buffer
(50 mM NaPO4 [pH 6.0], 300 mM NaCl, 10% glycerol, 10 mM
2-mercaptoethanol, 0.1% Triton X-100, 0.1% Nonidet P-40) and eluted
with H1 binding buffer (10 mM Tris [pH 7.5], 100 mM NaCl) containing
200 mM imidazole. The imidazole was removed by dialysis at 4°C
against H1 binding buffer. The final concentrations of E1N and CAT were
0.6 and 0.2 mg/ml, respectively.
E1 affinity chromatography.
The CAT and E1N affinity columns
were constructed by binding purified CAT and E1N to
Ni2+-agarose; CAT and E1N were used in excess to ensure
saturation of the Ni2+-agarose. Unbound protein was removed
with Ni2+ wash buffer. To confirm that equal amounts of CAT
and E1N were bound, equal volumes of each resin were analyzed by
SDS-PAGE and Coomassie blue staining. NME or nucleosomes were bound to
the affinity resins in digestion buffer by the batch method overnight at 4°C. Samples were loaded onto columns plugged with siliconized glass wool, and unbound proteins were allowed to flow through the
column. Columns were washed at 4°C with 50 volumes of digestion buffer and then with lysis buffer (50 mM Tris [pH 8], 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate) until eluting proteins were undetectable by measurement of optical density at 280 nm. For
affinity chromatography of NME, columns were eluted at 4°C with lysis
buffer containing 0.05% SDS. For affinity chromatography of
nucleosomes, columns were washed successively at 4°C with lysis buffers containing 2 M NaCl and 8 M urea and then eluted at 4°C with
lysis buffer at pH 6.0.
Microsequence analysis.
Proteins were resolved by SDS-PAGE
and transblotted to a polyvinylidene difluoride membrane (Bio-Rad). The
membrane was stained for protein with Ponceau S (Sigma Chemical
Company, St. Louis, Mo.) in accordance with the procedure of Harlowe
and Lane (28), and the 34-kDa band was excised from the
membrane. The remaining protein analysis was performed by Harvard
Microchem (Cambridge, Mass.). Protein in the excised membrane was
digested with trypsin, and proteolytic peptide fragments were resolved
by reverse-phase high-performance liquid chromatography. The amino acid
sequences of four peptides were obtained by Edman degradation
(40). A BLAST search (2) of the nonredundant
protein database at the National Center for Biotechnology Information
was used to identify sequences homologous to those obtained by amino
acid sequencing.
Immunoprecipitations.
Two dishes each of HeLa cells were
infected with 2F for expression of the adenovirus fiber protein or
coinfected with vTF-7.3 and vEE1 for expression of the HPV-11 E1
protein. At 16 h p.i., the cells were lysed in 1 ml of lysis
buffer, and nuclei were then sedimented at 400 × g for
5 min at 4°C. Nuclei were extracted with digestion buffer containing
700 mM NaCl, and residual proteins were removed by centrifugation as
described above. The supernatant was treated with DNase I for 15 min at
room temperature. Nucleosome extract aliquots of equal volume were
reacted in solution with either the RL-070 E1 antiserum, the anti-H1
antibody AE4, or the antifiber antibody 4D2 for 2 h at room
temperature. Immune complexes were precipitated by binding to
formalin-fixed, heat-killed Staphylococcus aureus cells
(Immunoprecipitin; GIBCO-BRL Life Technologies, Gaithersburg, Md.) for
30 min at room temperature and centrifuged at 400 × g for 3 min. Immunoprecipitates were washed four times with 0.5 ml of
lysis buffer for 10 min each and finally centrifuged through a 3-ml
cushion of 1 M sucrose-containing lysis buffer at 3,300 × g for 5 min at room temperature. Immunoprecipitates were
analyzed by Western blot analysis. During the Western blot analysis,
the blots were additionally blocked with unconjugated secondary goat anti-mouse or goat anti-rabbit antibodies to reduce the signals generated by immunoglobulins on the blots.
DNase I protection assays.
The histone H1-DNA binding and
DNase I protection assays were adapted from the methods of Izaurralde
et al. (33). The HPV-11 genome, cloned at its
BamHI site into the pGEM-1 vector (Promega, Madison, Wis.),
was digested with BamHI and NdeI, and the
restriction fragments were end labeled by filling in the cohesive
termini, using the Klenow fragment of DNA polymerase I and
[
-32P]dATP. Unincorporated nucleotides were removed by
gel filtration, using a Microspin S-400 HR column (Pharmacia Biotech,
Piscataway, N.J.). Chicken erythrocyte histone H1 (200 ng) was bound to
200 ng of the labeled restriction fragments in 20 ml of H1 binding buffer for 30 min at room temperature. MgCl2 was added to
the reaction mixtures (final concentration, 10 mM), and DNA was
digested with 0.2 ng of DNase I for 5 min at room temperature. SDS and EDTA (final concentrations, 0.5% and 5 mM, respectively) were then
added prior to digestion with 20 mg of proteinase K at 55°C for
2 h. Following extraction with phenol-chloroform-isoamyl alcohol (25:24:1) and ethanol precipitation, protected restriction fragments were analyzed by agarose gel electrophoresis followed by detection and
analysis of the distribution of radioactivity, visualized on a Storm
PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.). For the E1
displacement experiment (see Fig. 6), E1N or CAT was added to the
reaction mixtures following H1-DNA binding, and the mixtures were
incubated for 15 min at room temperature. For the salmon sperm DNA
competition experiment (see Fig. 7), salmon sperm DNA was added at the
beginning of the H1-DNA reactions.
 |
RESULTS |
Expression of the HPV-11 E1 protein from a recombinant vaccinia
virus.
For expression of the HPV-11 E1 protein in mammalian cells,
the T7 RNA polymerase-vaccinia virus expression system developed by
Moss et al. was used (21, 24). An E1-encoding recombinant vaccinia virus (vEE1) that expressed E1 under the control of the T7 RNA
polymerase promoter was constructed (Fig.
1A). The E1 ORF was fused at its 5' end
to the EMCV UTR to confer cap-independent protein translation on
uncapped T7 RNA polymerase-generated mRNAs. Expression of E1 was
achieved by coinfection of HeLa cells with vEE1 and vTF7-3, the
recombinant vaccinia virus encoding T7 RNA polymerase (24).
Western blotting of the infected-cell lysates with antiserum specific
for E1 detected two proteins, with estimated molecular masses of 88 and
68 kDa (Fig. 1B). These bands represent E1-encoded proteins, since they
were absent from cells infected with vTF7-3 alone. Except for their
masses, the two E1 forms had no identifiable distinguishing features.
Both proteins reacted with antisera raised against N- or C-terminal
portions of HPV-11 E1 (data not shown). The 88-kDa species represents
the full-length, 649-amino-acid protein encoded by the E1 ORF, while
the 68-kDa form may result from E1 proteolysis or from internal protein
translation initiation. Santucci et al. (52) also reported
the expression of multiple forms of E1 from vaccinia virus; the major
forms had estimated molecular masses of 72 and 88 kDa. In vitro
translation of mRNA derived in vitro from plasmid pTFEE1 also yielded
two major E1 products with the same molecular weights, indicating that
the two E1 forms are not an artifact of expression by vaccinia virus
(data not shown).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Expression of recombinant E1 from vEE1. (A) mRNA
expression was under the control of the bacteriophage T7 RNA polymerase
promoter (PT7) and terminator (T7ter). Cap-independent translation was
directed by the EMCV UTR, which was fused to the 5' end of the E1 ORF.
The resulting operon was recombined into the TK gene (TKL
and TKR) of vaccinia virus. The arrow indicates the
direction of transcription, and the closed circle represents the T7
terminator of transcription. (B) Equal volumes of whole-cell lysates
from HeLa cells infected with vTF-7.3 and vEE1 (+) or with vTF-7.3
alone ( ) were resolved by SDS-PAGE on a 10% polyacrylamide gel and
assayed for recombinant E1 protein by Western blot analysis with the E1
antiserum RL-070, biotinylated secondary antibody, and
35S-streptavidin. The image was generated by PhosphorImager
analysis (Molecular Dynamics). The positions of molecular mass markers
(in kilodaltons) are shown on the right.
|
|
E1 binds to histone H1 in vitro.
A far-Western blot analysis
was used to identify proteins in HeLa cell nuclei that bind to the E1
protein (Fig. 2). A truncated form of the
E1 protein (E1N) was used as a probe in this analysis. E1N contains the
amino-terminal 185 amino acids of E1 and was expressed in and purified
from E. coli as a polyhistidine-tagged fusion protein. As a
negative control in far-Western blot analysis, the CAT protein was used
as a probe; it was also expressed and purified from E. coli
as a polyhistidine-tagged fusion protein. An antibody (His-probe) that
recognizes the polyhistidine tags present on both the E1N and CAT
proteins was used to detect E1-reactive proteins on the far-Western
blot. We used protein from the nuclear matrix fraction to probe for
E1-binding proteins, since the nuclear matrix is known to be the site
of eukaryotic and viral DNA replication (6, 15, 16, 35, 48)
as well as E1 localization (63). The nuclear matrix is
operationally defined as the subnuclear structure remaining after
removal of chromatin from isolated nuclei by DNase I digestion and
subsequent extraction with either 2 M NaCl or the nonionic detergent
LIS. The nuclear matrix is a complex mixture of protein and nucleic
acids and consists of the nuclear lamina, nuclear envelope, nucleoli,
and internal core filaments as well as many other uncharacterized
components (68). SV40 DNA replication, which relies on the
host cell's replication machinery to the same extent as that of
papillomaviruses, also occurs in association with this nuclear
substructure (29, 53, 60). In fact, the nuclear matrix has
been implicated as the site of occurrence of most nuclear processes,
including transcription and RNA processing (5, 34, 59, 66).
The E1N protein bound to a doublet band migrating at 34 and 35 kDa.
This interaction was specific for the E1N protein, since no reactivity
of the CAT proteins with these bands was observed. The nonspecific
reactive band at approximately 55 kDa on both the experimental and the control blots is a nuclear component that reacts with the His-probe antibody.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 2.
Far-Western blot analysis of HeLa cell nuclear proteins
with the E1N protein. A 0.5-mg quantity of nuclear protein was resolved
by SDS-PAGE on a 12.5% polyacrylamide slab gel, transblotted to
nitrocellulose, and renatured. Strips cut from the blot were probed
with the CAT or E1N protein. E1N-reactive proteins were detected by
reaction with His-probe antiserum and enhanced chemiluminescence. The
left strip is total nuclear matrix protein, stained with Coomassie
blue, derived from the same gel as the far-Western blots. The positions
of molecular mass markers (in kilodaltons) are shown on the right.
|
|
The E1-binding proteins were affinity purified from NME for their
identification by microsequence analysis. NME was prepared
by
extraction of nuclear matrices with 8 M urea followed by removal
of the
urea by dialysis. An E1 affinity column was constructed
by binding the
E1N protein to nickel-agarose. A similar column,
constructed with the
CAT protein, was used as a control for nonspecific
binding of NME
proteins. The columns were loaded with NME, washed
extensively to
remove nonspecifically bound proteins, and eluted
with 0.5% SDS. The
silver-stained SDS-PAGE gel of the column fractions
is shown in Fig.
3.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 3.
Purification of E1-bound proteins by E1 affinity
chromatography. Protein from a dialyzed HeLa cell NME was loaded onto
an E1N (+) or a CAT ( ) affinity column. Bound proteins were washed
with Ni2+ wash buffer and were eluted with lysis buffer
containing 0.5% SDS. Equal volumes from the flowthrough, wash, and
eluate fractions were resolved by SDS-PAGE and detected by silver
staining. Crude NME was loaded in the far left lane. The positions of
molecular mass markers (in kilodaltons) are shown on the left. The
arrow indicates the position of the protein doublet.
|
|
The same protein doublet evident in Fig.
2 was bound by and eluted from
the E1 column. Its association with the column was
E1 dependent, since
it was not bound by the CAT column. The 34-kDa
band from the eluate was
processed for microsequencing analysis
by Harvard Microchem as
described in Materials and Methods. The
amino acid sequences of four
tryptic peptides (SGVSLAALK, ALAAAGYDVEK,
ELTDSGYGYSEVEAATQVEK, and
GTLVQTK) were obtained. As shown by
a BLAST search (
2) of
the nonredundant protein database at
the National Center for
Biotechnology Information, these sequences
were identical to ones
present in human histone H1. H1 is known
to be a nucleus-localized
protein for which six isoforms have
been identified; they migrate as
two distinct bands near 34 and
35 kDa in one-dimensional SDS-PAGE
(
13,
14). These data verify
that H1 isolated from HeLa cell
nuclei binds directly to E1 in
vitro.
The relative abundance of histone H1 in the crude NME is likely
exaggerated in Fig.
3 due to our silver staining method, since
it was
not evident in such relative abundance when stained with
Coomassie blue
(data not shown). Also, H1 was not present in such
relative abundance
in preparations of total nuclear matrix proteins,
as shown in Fig.
2.
As a result, we do not feel that the observed
interaction between E1
and H1 is a nonspecific one attributable
to the relative abundance of
H1 in the extracts used in these
experiments. Because H1 is a highly
basic and lysine-rich protein,
we assessed the contribution of lysines
and ionic charges to the
E1-H1 interaction by eluting the column with
0.5 M lysine and
2 M NaCl, respectively. H1 failed to elute from the
column under
either condition, indicating that the E1-H1 interaction is
not
mediated by nonspecific association between lysines or ionic
charges
(data not shown). Furthermore, as will be described below (see
also Fig.
4), the E1-H1 interaction was also shown to be resistant
to 8 M urea. These data suggest that the observed interaction
between E1 and
H1 is specific.
In both the far-Western blot analysis and affinity purification, the
analyzed proteins were denatured at some point prior
to E1 binding.
Although protein renaturation was attempted in
both cases, the native
state of H1 was not affirmed. In a protocol
employing no protein
denaturants, H1 was isolated in its native
state in association with
intact nucleosomes from micrococcal-nuclease-treated
nuclei, as
described by von Holt et al. (
69). The nucleosome
preparation contained H1 as well as core histones, and its DNA
composition was characteristic of mononucleosomal DNA (data not
shown).
The nucleosome extract was applied to an E1 column, which
was washed
and eluted with 8 M urea followed by a low-pH (6.0)
buffer. A duplicate
E1 column was loaded with nucleosome buffer
alone and processed in the
same manner; this control was designed
to detect eluting proteins which
might originate from the affinity
column itself instead of the extract.
Interestingly, H1 failed
to elute from the column with 8 M urea (data
not shown). Conditions
tested that eluted H1 were 0.5% SDS and low pH
(pH 6.0). Figure
4 shows the
Coomassie-stained SDS-PAGE gel of the low-pH eluates.
The
identification of the proteins in the E1 column eluate as
H1 was
confirmed as follows. (i) They were recognized by an H1
antiserum in a
Western blot analysis (data not shown). (ii) They
were absent in the
eluate from the column loaded with buffer alone,
indicating that they
originated from the nucleosome preparation.
The binding of H1 to the
affinity column was E1 dependent, since
H1 did not bind to CAT protein
immobilized on a similar nickel
column. The association of H1 with E1
was not mediated by core
histones, since they were not present in the
eluate. The 28-kDa
protein seen in the CAT column eluate is a fraction
of the CAT
protein which dissociated from the nickel-agarose at low pH.
This
behavior was not observed with the E1N column, since no E1 protein
was detected in its eluate by Western blot analysis (data not
shown).
These data demonstrate that the E1 protein bound in vitro
to H1 which
was isolated under native conditions in association
with nucleosomes.
Moreover, taken with the resistance to high
ionic strength, the pH
dependence of the interaction may reflect
a dependence on protein
conformation.

View larger version (104K):
[in this window]
[in a new window]
|
FIG. 4.
Association of histone H1, isolated under native
conditions, with the E1 affinity column. Protein from a nucleosome
extract (lanes 3 and 4) or nucleosome extract buffer alone (lanes 5 and
6) was loaded onto an E1N (lanes 4 and 6) or a CAT (lanes 3 and 5)
affinity column, washed with Ni2+ wash buffer supplemented
with 8 M urea, and eluted with pH 6.0 lysis buffer. Equal volumes of
protein from the columns' eluates were resolved by SDS-PAGE on a 15%
polyacrylamide gel. Resolved proteins were detected by Coomassie
brilliant blue staining. Proteins from crude NME and the flowthrough
from the NME-loaded E1 column were loaded in lanes 1 and 2, respectively. Protein molecular mass standards (in kilodaltons) were
loaded in the far-left lane.
|
|
E1 was associated with histone H1 in vivo.
To demonstrate the
E1-H1 complex in vivo, we coimmunoprecipitated E1 and H1 from a nuclear
extract made from HeLa cells expressing recombinant E1. Nuclear
extracts were prepared from HeLa cell cultures expressing the HPV-11 E1
protein or the adenovirus fiber protein, each from recombinant vaccinia
viruses, and immunoprecipitated with the E1 antiserum RL-070, the
anti-H1 antibody AE4, or the antifiber antibody 4D2. The Western blots
of the immunoprecipitates are shown in Fig.
5. The E1 antiserum coimmunoprecipitated
H1 with E1 from the lysate derived from E1-expressing HeLa cells. H1's
association with E1 immune complexes did not result from nonspecific
interaction with the E1 antiserum, since H1 was not immunoprecipitated
from lysates derived from cells expressing the fiber protein instead.
In addition, the anti-H1 antibody coimmunoprecipitated E1 with H1 from
cells expressing E1. Immunoprecipitation of E1 or H1 by their
respective immune reagents was specific, as shown by their absence from
immune complexes formed with heterologous antibodies. To dismiss the
possibility that the observed E1-H1 complexes are an artifact of
overexpression from vaccinia virus and result from nonspecific
interactions, we assayed for coimmunoprecipitation of a different
nucleus-localized protein expressed from vaccinia virus. The adenovirus
fiber protein was expressed in HeLa cells from vaccinia virus. Immune
complexes derived from a nuclear extract of the fiber-expressing cells
were formed by using an antifiber or anti-H1 antibody, and the presence
of the fiber protein or H1 was determined by Western blot analysis
(Fig. 5C). Coimmunoprecipitation of the fiber protein and H1 was not
observed with either antibody, indicating that the observed E1-H1
complexes were not an artifact of E1 overexpression from vaccinia
virus. These data support the notion of an intranuclear complex formed
specifically between the E1 protein and histone H1 in vivo.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 5.
Coimmunoprecipitation of histone H1 and HPV-11 E1.
Nuclear extracts derived from HeLa cells expressing the HPV-11 E1
(vEE1) or adenovirus fiber (2F) protein, each from vaccinia virus, were
incubated with (+) or without ( ) E1 antiserum ( -E1), anti-H1
antibody ( -H1), and antifiber antibody ( -fiber).
Immunoprecipitates were assayed for H1 (A), E1 (B), or fiber (C) by
Western blot analysis and enhanced chemiluminescence. The asterisks
denote the heavy and light chains of immunoglobulins used in the
immunoprecipitations. The band in panel B denoted by the uppermost
asterisk is derived from the E1 antiserum and is likely incompletely
denatured immunoglobulin. Positions of molecular mass markers (in
kilodaltons) are shown on the left.
|
|
E1 displaces H1 from DNA.
H1 is a linker histone that binds to
regions of DNA between adjacent nucleosomes, condensing chromatin into
a more highly ordered structure. Alteration of H1 binding to chromatin
alters the more highly ordered structure of chromatin, which can affect chromatin-dependent processes such as gene expression and DNA replication (64). We tested the hypothesis that binding by
E1 alters the association of H1 with DNA and influences chromatin structure. To assay for H1 association with DNA, we used the H1-DNA binding and DNase I protection assays describe by Izaurralde et al.
(33). H1 binds nonspecifically but tightly to DNA,
protecting it from digestion by DNase I. Because this assay only
assesses H1's association with naked DNA, and papillomavirus DNA
exists as chromatin in vivo, the physiological relevance of this assay is questionable. However, H1's association with chromatin occurs via
direct interaction with DNA; the core histones comprising the octamer
do not mediate or stabilize the association. We therefore feel that
this assay suffices to assess DNA binding by H1 and that results
obtained with this assay may be extended to chromatin in vivo.
32P-labeled HPV-11 DNA restriction fragments were bound to
purified chicken erythrocyte H1 and subsequently incubated with
increasing amounts E1N. The samples were then digested with DNase I and
analyzed by agarose gel electrophoresis and autoradiography. The
autoradiograph of the agarose gel is shown in Fig.
6. E1N diminished the association of H1
with the DNA fragments in a dose-dependent manner. Protection from
DNase I digestion was eliminated with 800 ng of E1, whereas up to 2 µg of the CAT protein had a minimal effect on the association of H1
with the DNA fragments. These data indicate that interaction between E1
and histone H1 results in displacement of H1 from DNA.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 6.
Displacement of H1 from HPV-11 DNA by E1. Two hundred
nanograms of 32P-labeled HPV-11 DNA restriction fragments
were bound to 200 ng of H1; this was followed by incubation with (+) or
without ( ) the indicated amounts (in micrograms) of E1N or CAT and,
finally, digestion with DNase I. H1-bound restriction fragments were
protected from digestion by DNase I; displacement of H1 by E1N is
indicated by removal of labeled DNAs by DNase I digestion. The image
was generated by PhosphorImager analysis (Molecular Dynamics). (B)
Linearized map of HPV-11 DNA restriction fragments A to E. Arrows
denote viral protein ORFs. The noncoding region between the E6 and L1
ORFs is the URR and contains the HPV-11 origin of DNA replication.
|
|
Regions within the HPV-11 genome have differential affinities for
H1.
Certain DNAs have been shown to have differential affinities
for H1 (33). Regions within the SV40 genome, at the origin of replication and early promoter, with resistance to H1 binding were
previously identified (30). We looked for such regions within the HPV-11 genome by using the DNase I protection assay described in the legend to Fig. 6. H1 was incubated with the labeled HPV-11 restriction fragments in the presence of increasing amounts of
salmon sperm DNA as a nonspecific DNA binding competitor. Samples were
digested with DNase I and analyzed by agarose gel electrophoresis and
autoradiography. The results are shown in Fig.
7. Salmon sperm DNA competed with H1 for
association with each of the restriction fragments. However, regions
with differential affinities for H1 were identified at lower
concentrations of competing salmon sperm DNA. Fragments 3 and 5 were
weaker-binding fragments. These fragments span nucleotides 7658 to
1101, a sequence which contains the 5' portion of the protein coding
region and the 3' portion of the upstream regulatory region (URR),
including the origin of replication (Fig. 7). They are not contiguous
and are separated by a 117-bp restriction fragment.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 7.
Differential affinities of HPV-11 restriction fragments
for binding to histone H1. 32P-labeled HPV-11 DNA
restriction fragments were bound to 200 ng of H1 in the presence (+) or
absence ( ) of the indicated amounts of salmon sperm DNA (ssDNA)
followed by digestion with DNase I. H1-bound restriction fragments were
protected from digestion by DNase I; competition for H1 binding by
salmon sperm DNA resulted in removal of labeled DNAs by DNase I
digestion. Differential affinity for H1 among the restriction fragments
is indicated by the differing amount of competition at 60 µg of
salmon sperm DNA. HPV DNA restriction fragments are labeled according
to the map in Fig. 6B. The image was generated by PhosphorImager
analysis (Molecular Dynamics).
|
|
 |
DISCUSSION |
Histone H1 binds to nucleosome-organized chromatin at regions of
DNA between adjacent nucleosomes, condensing chromatin into a more
highly ordered structure (64). The SV40 and bovine
papillomavirus type 1 (BPV-1) genomes are known to be complexed with
nucleosomes and to be organized into conventional chromatin structures
(23, 36, 49). However, replication of both of these viral
DNAs in vitro is repressed by the presence of nucleosomes on the
template (10, 19, 37, 56). Each of these viruses must have a
means of overcoming this repression (18). Nucleosomal
repression of DNA replication is postulated to occur during both
initiation and chain elongation. During initiation, nucleosomes
interfere with interactions between replication factors and the origin
(10, 56). They must be displaced for site-specific DNA
interactions to occur. They also act as obstacles for the DNA
polymerase during chain elongation by impeding progression of the
replication fork. They must be disrupted in front of the replication
fork and reassembled behind it, onto daughter strands, once the fork
has passed (1, 26, 46, 67). Work by Ramsperger and Stahl
(51) suggested that these tasks are accomplished by the
large T antigen during SV40 DNA replication. T antigen was shown to
bind nucleosomal SV40 origin DNA and displace core octamers in the
process. It also unwound nucleosomal DNA in a helicase assay.
Furthermore, T antigen bound directly to histones H1 and H3, suggesting
that nucleosome disruption by T antigen is facilitated through these interactions. Li and Botchan (42) demonstrated that
nucleosomal repression of in vitro BPV-1 DNA replication was relieved
by site-specific binding of the E2 protein to viral DNA. This result
indicates that E2, not E1, is responsible for nucleosomal disruption
during BPV-1 DNA replication and that E2 plays an additional role in replication initiation besides recruitment of E1 to the origin. Perhaps
our failure to observe an interaction between E1 and the core histones
is a further indication that E1 plays no role in nucleosome disruption.
What is the function of the interaction of E1 with H1? Li and Botchan
did not assess the effect of H1-organized nucleosomes on replication,
since their templates contained no H1. The presence of H1 on the
template presents an additional obstacle during DNA replication.
Accessibility of the origin to replication factors should be further
constrained, and nucleosome disruption during chain elongation should
be impaired. During initiation of HPV DNA synthesis, the chromatin
structure at the viral origin may be critical and require loosening for
recognition by the E1-E2 complex to occur. This could be facilitated by
displacement of H1 from DNA by E1. Most studies have implicated the
E1-E2 complex as the form of E1 likely to function during initiation of
HPV DNA synthesis (12, 17, 58, 65, 70), and both E1 and E2
were required to initiate in vitro BPV-1 DNA synthesis on
nucleosome-organized templates (42). Consequently, E1 may
displace H1 from DNA while complexed with E2. Because we did not assess
the ability of E1-E2 complexes to displace H1, the physiological
relevance of the experiment of Fig. 6 to replication initiation is
limited. Recent work by Gasser et al. (25) suggested a model
for nucleosome disruption during the elongation phase of DNA synthesis
in which H1 dissociates from the first one or two nucleosomes ahead of
the replication fork. E1 may serve a role during chain elongation in
addition to its DNA helicase activity by displacing H1 ahead of the
replication fork. E2's only identified role in replication is origin
recognition, occurring during initiation. No role for E2 during chain
elongation has yet been suggested. In fact, E2 may dissociate from E1
and the replication complex following initiation and be absent from the
replication fork altogether during chain elongation. As a result, H1
displacement during chain elongation may be induced by E1 in the
absence of E2, and the H1 displacement seen in Fig. 6 may be more
representative of events occurring during chain elongation than of
those taking place during initiation; however, it does not rule out the
possibility that E1 displaces H1 while complexed with E2. T antigen may
provide similar functions for SV40 DNA replication through its
interaction with H1, although an ability to affect the interaction of
H1 with DNA has not been demonstrated. The data presented in this paper
suggest that both E1 and T antigen share this additional function apart
from their roles as DNA helicases.
Late in infection, SV40 DNA is depleted of nucleosomes at the origin
(3). Although this observation may be explained by occupation of the origin by T antigen, work by Hendrickson and Cole
(30) suggested that the DNA structure around the origin may
also contribute to this nucleosome depletion. Restriction fragments
containing the SV40 origin were resistant to binding of histones H1 and
H4 relative to other regions of the genome. Nucleotides flanking the AT
element within the origin were underprotected from DNase I digestion by
H1 and hypersensitive to hydroxyl radical cleavage (30). In
this paper, we showed that a 511-bp restriction fragment containing the
HPV-11 origin of replication was also resistant to H1 binding relative
to the majority of other regions of the genome. This property is not
limited to sequences around the origin, since a second fragment
containing a region 3' to the URR behaved similarly. Although these two
fragments are not contiguous and are separated by 117 bp, the structure
responsible for this resistance may extend into both regions contained
in the fragments. These data correlate with those presented by
Hendrickson and Cole (30) for SV40 DNA, which showed that a
similar resistance was conferred on an origin-containing fragment of
366 bp. They suggested that regions around papovavirus origins of DNA
replication have a common DNA structure that excludes histone H1 from
binding.
 |
ACKNOWLEDGMENTS |
We thank Louise T. Chow for the gifts of numerous plasmids and
antisera against HPV-11 E1. Plasmid pTF7.5 and recombinant vaccinia
viruses (wild type and vTF7-3) were obtained from Bernard Moss. We
thank Willie Thomas for assisting us with the large-scale culturing of
HeLa cells.
This work was supported by NIH grant AI20408 (to J.A.E.). C.S.S. was
supported in part by NIH training grant T32 CA09467 (to E. Hunter).
Support for the synthesis of oligonucleotides used in construction of
clones was provided though NCI grant CA13148 to the Comprehensive
Cancer Center.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Genetics, Schools of Medicine and Dentistry, University of Alabama at Birmingham, 1918 University Blvd., Rm. 460 MCLM, Birmingham, AL 35294-0005. Phone: (205) 934-4734. Fax: (205)
934-0758. E-mail: jengler{at}bmg.bhs.uab.edu.
 |
REFERENCES |
| 1.
|
Adams, C. C., and J. L. Workman.
1993.
Nucleosome displacement in transcription.
Cell
72:305-308[Medline].
|
| 2.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[Medline].
|
| 3.
|
Ambrose, C.,
V. Blasquez, and M. Bina.
1986.
A block in initiation of simian virus 40 assembly results in the accumulation of minichromosomes containing an exposed regulatory region.
Proc. Natl. Acad. Sci. USA
83:3287-3291[Abstract/Free Full Text].
|
| 4.
|
Angeletti, P. C., and J. A. Engler.
1996.
Tyrosine kinase-dependent release of an adenovirus preterminal protein complex from the nuclear matrix.
J. Virol.
70:3060-3067[Abstract].
|
| 5.
|
Berezney, R.
1991.
The nuclear matrix: a heuristic model for investigating genomic organization and function in the cell nucleus.
J. Cell. Biochem.
47:109-123[Medline].
|
| 6.
|
Berezney, R.
1984.
.
Organization and function of the nuclear matrix.
CRC Press, Boca Raton, Fla.
|
| 7.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[Medline].
|
| 8.
|
Broker, T. R.,
L. T. Chow,
M. T. Chin,
C. Rhodes,
S. M. Wolinsky,
A. Whitbeck, and M. H. Stoler.
1989.
A molecular portrait of human papillomavirus carcinogenesis.
Cancer Cells
7:197-208.
|
| 9.
|
Challberg, M. D., and T. J. Kelly.
1979.
Adenovirus DNA replication in vitro.
Proc. Natl. Acad. Sci. USA
76:655-659[Abstract/Free Full Text].
|
| 10.
|
Cheng, L., and T. J. Kelly.
1989.
Transcriptional activator nuclear factor I stimulates the replication of SV40 minichromosomes in vivo and in vitro.
Cell
59:541-551[Medline].
|
| 11.
|
Chiang, C.-M.,
T. R. Broker, and L. T. Chow.
1991.
An E1M E2C fusion protein encoded by human papillomavirus type 11 is a sequence-specific transcription repressor.
J. Virol.
65:3317-3329[Abstract/Free Full Text].
|
| 12.
|
Chiang, C.-M.,
M. Ustav,
A. Stenlund,
T. F. Ho,
T. R. Broker, and L. T. Chow.
1992.
Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.
Proc. Natl. Acad. Sci. USA
89:5799-5803[Abstract/Free Full Text].
|
| 13.
|
Cole, R. D.
1987.
Microheterogeneity in H1 histones and its consequences.
Int. J. Pept. Protein Res.
30:433-444[Medline].
|
| 14.
|
Cole, R. D.
1984.
A minireview of microheterogeneity in H1 histone and its possible significance.
Anal. Biochem.
136:24-30[Medline].
|
| 15.
|
Cook, P. R.
1991.
The nucleoskeleton and the topology of replication.
Cell
66:627-635[Medline].
|
| 16.
|
DeBruyn Kops, A., and D. M. Knipe.
1988.
Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein.
Cell
55:857-868[Medline].
|
| 17.
|
Del Vecchio, A. M.,
H. Romanczuk,
P. M. Howley, and C. C. Baker.
1992.
Transient replication of human papillomavirus DNAs.
J. Virol.
66:5949-5958[Abstract/Free Full Text].
|
| 18.
|
DePamphilis, M. L.
1993.
Eukaryotic DNA replication: anatomy of an origin.
Annu. Rev. Biochem.
62:29-63[Medline].
|
| 19.
|
DePamphilis, M. L., and M. K. Bradley.
1986.
Replication of SV40 and polyomavirus chromosomes, p. 99-246. In
N. P. Salzman (ed.), The polyomaviruses, vol. 1.
Plenum Publishing Corporation, New York, N.Y.
|
| 20.
|
Dollard, S. C.,
J. L. Wilson,
L. M. Demeter,
W. Bonnez,
R. C. Reichman,
T. R. Broker, and L. T. Chow.
1992.
Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures.
Genes Dev.
6:1131-1142[Abstract/Free Full Text].
|
| 21.
|
Elroy-Stein, O.,
T. R. Fuerst, and B. Moss.
1989.
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
Proc. Natl. Acad. Sci. USA
86:6126-6130[Abstract/Free Full Text].
|
| 22.
|
Erlich, H. A.
1992.
.
PCR technology: principles and applications for DNA amplification. W. H.
Freeman and Company, New York, N.Y.
|
| 23.
|
Favre, M.,
F. Breitburd,
O. Croissant, and G. Orth.
1977.
Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses.
J. Virol.
21:1205-1209[Abstract/Free Full Text].
|
| 24.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 25.
|
Gasser, R.,
T. Koller, and J. M. Sogo.
1996.
The stability of nucleosomes at the replication fork.
J. Mol. Biol.
258:224-239[Medline].
|
| 26.
|
Gruss, C., and J. M. Sogo.
1992.
Chromatin replication.
Bioessays
14:1-8[Medline].
|
| 27.
|
Ham, J.,
N. Dostatni,
J. M. Gauthier, and M. Yaniv.
1991.
The papillomavirus E2 protein: a factor with many talents.
Trends Biochem. Sci.
16:440-444[Medline].
|
| 28.
|
Harlowe, E., and D. Lane.
1988.
.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 29.
|
Harper, F.,
Y. Florentin, and E. Puvion.
1985.
Large T antigen-rich viral DNA replication loci in SV40-infected monkey kidney cells.
Exp. Cell Res.
161:434-444[Medline].
|
| 30.
|
Hendrickson, F. M., and R. D. Cole.
1994.
Selectivity in the interaction of various DNA sequences with H1 histone.
Biochemistry
33:2997-3006[Medline].
|
| 31.
|
Hong, J. S., and J. A. Engler.
1991.
The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal.
Virology
185:758-767[Medline].
|
| 32.
|
Hong, J. S., and J. A. Engler.
1996.
Domains required for assembly of adenovirus type 2 fiber trimers.
J. Virol.
70:7071-7078[Abstract/Free Full Text].
|
| 33.
|
Izaurralde, E.,
E. Kas, and U. K. Laemmli.
1989.
Highly preferential nucleation of histone H1 assembly on scaffold-associated regions.
J. Mol. Biol.
210:573-585[Medline].
|
| 34.
|
Jackson, D. A.
1991.
Structure-function relationships in eukaryotic nuclei.
Bioessays
13:1-10[Medline].
|
| 35.
|
Jackson, D. A., and P. R. Cook.
1986.
Replication occurs at a nucleoskeleton.
EMBO J.
5:1403-1410[Medline].
|
| 36.
|
Keller, W.,
U. Muller,
I. Eicken,
I. Wendel, and H. Zentgraf.
1978.
Biochemical and ultrastructural analysis of SV40 chromatin.
Cold Spring Harbor Symp. Quant. Biol.
42:227-244.
|
| 37.
|
Kelly, T. J.
1988.
SV40 DNA replication.
J. Biol. Chem.
263:17889-17892[Free Full Text].
|
| 38.
|
Kuo, S. R.,
J. S. Liu,
T. R. Broker, and L. T. Chow.
1994.
Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts.
J. Biol. Chem.
269:24058-24065[Abstract/Free Full Text].
|
| 39.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 40.
|
Lane, W. S.
1991.
Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus.
J. Protein Chem.
10:151-160[Medline].
|
| 41.
|
Lee, W. S.,
C. C. Kao,
G. O. Bryant,
X. Liu, and A. J. Berk.
1991.
Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor.
Cell
67:365-376[Medline].
|
| 42.
|
Li, R., and M. R. Botchan.
1994.
Acidic transcription factors alleviate nucleosome-mediated repression of DNA replication of bovine papillomavirus type 1.
Proc. Natl. Acad. Sci. USA
91:7051-7055[Abstract/Free Full Text].
|
| 43.
|
McBride, A. A.,
H. Romanczuk, and P. M. Howley.
1991.
The papillomavirus E2 regulatory proteins.
J. Biol. Chem.
266:18411-18414[Free Full Text].
|
| 44.
|
Meyers, C.,
M. G. Frattini,
J. B. Hudson, and L. A. Laimins.
1992.
Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.
Science
257:971-973[Abstract/Free Full Text].
|
| 45.
|
Mohr, I. J.,
R. Clark,
S. Sun,
E. J. Androphy,
P. Macpherson, and M. R. Botchan.
1990.
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator.
Science
250:1694-1699[Abstract/Free Full Text].
|
| 46.
|
Morse, R. H.
1992.
Transcribed chromatin.
Trends Biochem. Sci.
17:23-26[Medline].
|
| 47.
|
Moss, B., and P. E. Earl.
1987.
-1997. Expression of proteins in mammalian cells using vaccinia viral vectors, p. 16.15.1-16.19.9. In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2.
John Wiley & Sons, Inc., New York, N.Y.
|
| 48.
|
Nakayasu, H., and R. Berezney.
1989.
Mapping replication sites in the eukaryotic cell nucleus.
J. Cell Biol.
108:1-11[Abstract/Free Full Text].
|
| 49.
|
Nedospasov, S. A.,
V. V. Bakayev, and G. P. Georgiev.
1978.
Chromosome of the mature virion of simian virus 40 contains H1 histone.
Nucleic Acids Res.
5:2847-2860[Abstract/Free Full Text].
|
| 50.
|
Park, P.,
W. Copeland,
L. Yang,
T. Wang,
M. R. Botchan, and I. J. Mohr.
1994.
The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase.
Proc. Natl. Acad. Sci. USA
91:8700-8704[Abstract/Free Full Text].
|
| 51.
|
Ramsperger, U., and H. Stahl.
1995.
Unwinding of chromatin by the SV40 large T antigen DNA helicase.
EMBO J.
14:3215-3225[Medline].
|
| 52.
|
Santucci, S.,
E. J. Androphy,
C. Bonne-Andréa, and P. Clertant.
1990.
Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells.
J. Virol.
64:6027-6039[Abstract/Free Full Text].
|
| 53.
|
Schirmbeck, R., and W. Deppert.
1991.
Structural topography of simian virus 40 DNA replication.
J. Virol.
65:2578-2588[Abstract/Free Full Text].
|
| 54.
|
Seo, Y. S.,
F. Muller,
M. Lusky, and J. Hurwitz.
1993.
Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication.
Proc. Natl. Acad. Sci. USA
90:702-706[Abstract/Free Full Text].
|
| 55.
|
Simon, R. H., and G. Felsenfeld.
1979.
A new procedure for purifying histone pairs H2A + H2B and H3 + H4 from chromatin using hydroxylapatite.
Nucleic Acids Res.
6:689-696[Abstract/Free Full Text].
|
| 56.
|
Simpson, R. T.
1990.
Nucleosome positioning can affect the function of a cis-acting DNA element in vivo.
Nature
343:387-389[Medline].
|
| 57.
|
Smale, S. T., and R. Tjian.
1986.
T-antigen-DNA polymerase complex implicated in simian virus 40 DNA replication.
Mol. Cell. Biol.
6:4077-4087[Abstract/Free Full Text].
|
| 58.
|
Spalholz, B. A.,
A. A. McBride,
T. Sarafi, and J. Quintero.
1993.
Binding of bovine papillomavirus E1 to the origin is not sufficient for DNA replication.
Virology
193:201-212[Medline].
|
| 59.
|
Spector, D. L.
1993.
Macromolecular domains within the cell nucleus.
Annu. Rev. Cell Biol.
9:265-315.
|
| 60.
|
Staufenbiel, M., and W. Deppert.
1983.
Different structural systems of the nucleus are targets for SV40 large T antigen.
Cell
33:173-181[Medline].
|
| 61.
|
Stoler, M. H.,
A. Whitbeck,
S. M. Wolinsky,
T. R. Broker,
L. T. Chow,
M. K. Howett, and J. W. Kreider.
1990.
Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice.
J. Virol.
64:3310-3318[Abstract/Free Full Text].
|
| 62.
|
Stoler, M. H.,
S. M. Wolinsky,
A. Whitbeck,
T. R. Broker, and L. T. Chow.
1989.
Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.
Virology
172:331-340[Medline].
|
| 63.
| Swindle, C. S., and J. A. Engler.
Unpublished results.
|
| 64.
|
Thoma, F.,
T. H. Koller, and A. Klug.
1979.
Involvement of histone H1 in the organization of the nucleosome and of the salt-dependent superstructures of chromatin.
J. Cell Biol.
83:403-427[Abstract/Free Full Text].
|
| 65.
|
Ustav, M., and A. Stenlund.
1991.
Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames.
EMBO J.
10:449-457[Medline].
|
| 66.
|
van Driel, R.,
B. Humbel, and L. de Jong.
1991.
The nucleus: a black box being opened.
J. Cell. Biochem.
47:311-316[Medline].
|
| 67.
|
van Holde, K. E.,
D. E. Lohr, and C. Robert.
1992.
What happens to nucleosomes during transcription?
J. Biol. Chem.
267:2837-2840[Free Full Text].
|
| 68.
|
Verheijen, R.,
W. V. Venroij, and F. Ramaekers.
1988.
The nuclear matrix: structure and composition.
J. Cell Sci.
90:11-36[Free Full Text].
|
| 69.
|
von Holt, C.,
W. F. Brandt,
H. J. Greyling,
G. G. Lindsey,
J. D. Retief,
J. D. Rodrigues,
S. Schwager, and B. T. Sewell.
1989.
Isolation and characterization of histones.
Methods Enzymol.
170:431-503[Medline].
|
| 70.
|
Yang, L.,
R. Li,
I. J. Mohr,
R. Clark, and M. R. Botchan.
1991.
Activation of BPV-1 replication in vitro by the transcription factor E2.
Nature
353:628-632[Medline].
|
| 71.
|
Yang, L.,
I. Mohr,
E. Fouts,
D. A. Lim,
M. Nohaile, and M. B. Botchan.
1993.
The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase.
Proc. Natl. Acad. Sci. USA
90:5086-5090[Abstract/Free Full Text].
|
J Virol, March 1998, p. 1994-2001, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lace, M. J., Anson, J. R., Turek, L. P., Haugen, T. H.
(2008). Functional Mapping of the Human Papillomavirus Type 16 E1 Cistron. J. Virol.
82: 10724-10734
[Abstract]
[Full Text]
-
Cote-Martin, A., Moody, C., Fradet-Turcotte, A., D'Abramo, C. M., Lehoux, M., Joubert, S., Poirier, G. G., Coulombe, B., Laimins, L. A., Archambault, J.
(2008). Human Papillomavirus E1 Helicase Interacts with the WD Repeat Protein p80 To Promote Maintenance of the Viral Genome in Keratinocytes. J. Virol.
82: 1271-1283
[Abstract]
[Full Text]
-
Ajay Kumar, R., Naidu, S. R., Wang, X., Imbalzano, A. N., Androphy, E. J.
(2007). Interaction of Papillomavirus E2 Protein with the Brm Chromatin Remodeling Complex Leads to Enhanced Transcriptional Activation. J. Virol.
81: 2213-2220
[Abstract]
[Full Text]
-
Longworth, M. S., Laimins, L. A.
(2004). Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev.
68: 362-372
[Abstract]
[Full Text]
-
He, W., Staples, D., Smith, C., Fisher, C.
(2003). Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7. J. Virol.
77: 10566-10574
[Abstract]
[Full Text]
-
West, M., Flanery, D., Woytek, K., Rangasamy, D., Wilson, V. G.
(2001). Functional Mapping of the DNA Binding Domain of Bovine Papillomavirus E1 Protein. J. Virol.
75: 11948-11960
[Abstract]
[Full Text]
-
Okun, M. M., Day, P. M., Greenstone, H. L., Booy, F. P., Lowy, D. R., Schiller, J. T., Roden, R. B. S.
(2001). L1 Interaction Domains of Papillomavirus L2 Necessary for Viral Genome Encapsidation. J. Virol.
75: 4332-4342
[Abstract]
[Full Text]
-
McShan, G. D., Wilson, V. G.
(2000). Contribution of bovine papillomavirus type 1 E1 protein residue 48 to replication function. J. Gen. Virol.
81: 1995-2004
[Abstract]
[Full Text]
-
Marechal, V., Dehee, A., Chikhi-Brachet, R., Piolot, T., Coppey-Moisan, M., Nicolas, J.-C.
(1999). Mapping EBNA-1 Domains Involved in Binding to Metaphase Chromosomes. J. Virol.
73: 4385-4392
[Abstract]
[Full Text]
-
Rangasamy, D., Wilson, V. G.
(2000). Bovine Papillomavirus E1 Protein Is Sumoylated by the Host Cell Ubc9 Protein. J. Biol. Chem.
275: 30487-30495
[Abstract]
[Full Text]
-
Rangasamy, D., Woytek, K., Khan, S. A., Wilson, V. G.
(2000). SUMO-1 Modification of Bovine Papillomavirus E1 Protein Is Required for Intranuclear Accumulation. J. Biol. Chem.
275: 37999-38004
[Abstract]
[Full Text]